329 related articles for article (PubMed ID: 27345973)
1. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying an A79V mutation in PSEN1.
Li T; Pires C; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Dinnyes A; Hyttel P; Freude KK
Stem Cell Res; 2016 Mar; 16(2):229-32. PubMed ID: 27345973
[TBL] [Abstract][Full Text] [Related]
2. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a M146I mutation in PSEN1.
Li T; Pires C; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Dinnyes A; Holst B; Hyttel P; Freude KK
Stem Cell Res; 2016 Mar; 16(2):334-7. PubMed ID: 27345998
[TBL] [Abstract][Full Text] [Related]
3. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a L150P mutation in PSEN-1.
Tubsuwan A; Pires C; Rasmussen MA; Schmid B; Nielsen JE; Hjermind LE; Hall V; Nielsen TT; Waldemar G; Hyttel P; Clausen C; Kitiyanant N; Freude KK; Holst B
Stem Cell Res; 2016 Jan; 16(1):110-2. PubMed ID: 27345792
[TBL] [Abstract][Full Text] [Related]
4. Generation of a gene-corrected isogenic control cell line from an Alzheimer's disease patient iPSC line carrying a A79V mutation in PSEN1.
Pires C; Schmid B; Petræus C; Poon A; Nimsanor N; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Hyttel P; Freude KK
Stem Cell Res; 2016 Sep; 17(2):285-288. PubMed ID: 27879212
[TBL] [Abstract][Full Text] [Related]
5. Derivation of induced pluripotent stem cells from a familial Alzheimer's disease patient carrying the L282F mutation in presenilin 1.
Poon A; Li T; Pires C; Nielsen TT; Nielsen JE; Holst B; Dinnyes A; Hyttel P; Freude KK
Stem Cell Res; 2016 Nov; 17(3):470-473. PubMed ID: 27789396
[TBL] [Abstract][Full Text] [Related]
6. Establishment of induced pluripotent stem cell line (ZZUi009-A) from an Alzheimer's disease patient carrying a PSEN1 gene mutation.
Wang Y; Jing N; Su L; Shi C; Zhang P; Wang Z; Sun H; Yang J; Liu Y; Wen X; Zhang J; Zhang S; Xu Y
Stem Cell Res; 2018 Mar; 27():30-33. PubMed ID: 29304399
[TBL] [Abstract][Full Text] [Related]
7. Generation of a gene-corrected isogenic control hiPSC line derived from a familial Alzheimer's disease patient carrying a L150P mutation in presenilin 1.
Poon A; Schmid B; Pires C; Nielsen TT; Hjermind LE; Nielsen JE; Holst B; Hyttel P; Freude KK
Stem Cell Res; 2016 Nov; 17(3):466-469. PubMed ID: 27789395
[TBL] [Abstract][Full Text] [Related]
8. Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous Y275X mutation in CYP7B1 (SPG5).
Hauser S; Höflinger P; Theurer Y; Rattay TW; Schöls L
Stem Cell Res; 2016 Sep; 17(2):437-440. PubMed ID: 27879220
[TBL] [Abstract][Full Text] [Related]
9. Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous R486C mutation in CYP7B1 (SPG5).
Höflinger P; Theurer Y; Schüle R; Schöls L; Hauser S
Stem Cell Res; 2016 Sep; 17(2):422-425. PubMed ID: 27879216
[TBL] [Abstract][Full Text] [Related]
10. Establishment of SPAST mutant induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia (HSP) patient.
Hauser S; Erzler M; Theurer Y; Schuster S; Schüle R; Schöls L
Stem Cell Res; 2016 Nov; 17(3):485-488. PubMed ID: 27789400
[TBL] [Abstract][Full Text] [Related]
11. Induced pluripotent stem cells (iPSCs) derived from a patient with frontotemporal dementia caused by a P301L mutation in microtubule-associated protein tau (MAPT).
Rasmussen MA; Hjermind LE; Hasholt LF; Waldemar G; Nielsen JE; Clausen C; Hyttel P; Holst B
Stem Cell Res; 2016 Jan; 16(1):70-4. PubMed ID: 27345788
[TBL] [Abstract][Full Text] [Related]
12. Induced pluripotent stem cells (iPSCs) derived from a patient with frontotemporal dementia caused by a R406W mutation in microtubule-associated protein tau (MAPT).
Rasmussen MA; Hjermind LE; Hasholt LF; Waldemar G; Nielsen JE; Clausen C; Hyttel P; Holst B
Stem Cell Res; 2016 Jan; 16(1):75-8. PubMed ID: 27345789
[TBL] [Abstract][Full Text] [Related]
13. Integration-free erythroblast-derived human induced pluripotent stem cells (iPSCs) from an individual with Ataxia-Telangiectasia (A-T).
Bhatt N; Ghosh R; Roy S; Gao Y; Armanios M; Cheng L; Franco S
Stem Cell Res; 2016 Sep; 17(2):205-207. PubMed ID: 27879207
[TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem cells (iPSCs) derived from a pre-symptomatic carrier of a R406W mutation in microtubule-associated protein tau (MAPT) causing frontotemporal dementia.
Rasmussen MA; Hjermind LE; Hasholt LF; Waldemar G; Nielsen JE; Clausen C; Hyttel P; Holst B
Stem Cell Res; 2016 Jan; 16(1):105-9. PubMed ID: 27345791
[TBL] [Abstract][Full Text] [Related]
15. Generation of one iPSC line (IMEDEAi006-A) from an early-onset familial Alzheimer's Disease (fAD) patient carrying the E280A mutation in the PSEN1 gene.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Castresana M; Aguillón D; Villegas A; Mastronardi CA; Espinosa LG; Arcos-Burgos M; Del Pozo Á; Herrán E; Gainza E; Isaza-Ruget M; Lopera F; Bachiller D
Stem Cell Res; 2019 May; 37():101440. PubMed ID: 31026686
[TBL] [Abstract][Full Text] [Related]
16. Generation of induced pluripotent stem cells (IRMBi001-A) from an Alzheimer's disease patient carrying a G217D mutation in the PSEN1 gene.
Auboyer L; Monzo C; Wallon D; Rovelet-Lecrux A; Gabelle A; Gazagne I; Cacheux V; Lehmann S; Crozet C
Stem Cell Res; 2019 Jan; 34():101381. PubMed ID: 30677723
[TBL] [Abstract][Full Text] [Related]
17. Induced pluripotent stem cells (iPSCs) derived from cerebrotendinous xanthomatosis (CTX) patient's fibroblasts carrying a R395S mutation.
Höflinger P; Hauser S; Theurer Y; Weißenberger S; Wilke C; Schöls L
Stem Cell Res; 2016 Sep; 17(2):433-436. PubMed ID: 27879219
[TBL] [Abstract][Full Text] [Related]
18. Generation of induced pluripotent stem cells (iPSCs) from a retinoblastoma patient carrying a c.2663G>A mutation in RB1 gene.
Zeng S; Liu L; Ouyang Q; Zhao Y; Lin G; Hu L; Li W
Stem Cell Res; 2016 Sep; 17(2):208-211. PubMed ID: 27879208
[TBL] [Abstract][Full Text] [Related]
19. Generation of optic atrophy 1 patient-derived induced pluripotent stem cells (iPS-OPA1-BEHR) for disease modeling of complex optic atrophy syndromes (Behr syndrome).
Hauser S; Schuster S; Theurer Y; Synofzik M; Schöls L
Stem Cell Res; 2016 Sep; 17(2):426-429. PubMed ID: 27879217
[TBL] [Abstract][Full Text] [Related]
20. Generation of an integration-free iPSC line, ICCSICi006-A, derived from a male Alzheimer's disease patient carrying the PSEN1-G206D mutation.
Díaz-Guerra E; Oria-Muriel MA; Moreno-Jiménez EP; de Rojasb I; Rodríguez C; Rodríguez-Traver E; Orera M; Hernándezb I; Ruizb A; Vicario C
Stem Cell Res; 2019 Oct; 40():101574. PubMed ID: 31627126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]